Recursion: Nvidia Sells Out, Collaboration Still Alive, Data Ahead

NVIDIA's exit from its Recursion Pharmaceuticals equity position weighed on sentiment, though the technical collaboration is ...

Recursion (RXRX) Q4 2025 Earnings Call Transcript

Need a quote from a Motley Fool analyst? Over the past decade, Recursion Pharmaceuticals, Inc. has built something truly special: a differentiated platform pioneering the integration of large-scale ...
IEEE

Brightness Perceiving for Recursive Low-Light Image Enhancement

Abstract: Due to the wide dynamic range in real low-light scenes, there will be large differences in the degree of contrast degradation and detail blurring of captured images, making it difficult for ...
Visual Studio Magazine

Decision Tree Regression from Scratch Without Pointers or Recursion Using C#

Dr. James McCaffrey presents a complete end-to-end demonstration of decision tree regression from scratch using the C# language. The goal of decision tree regression is to predict a single numeric ...
IEEE

Recursive Filtering for Discrete-Time Stochastic Complex Networks Under Bit-Rate Constraints: A Locally Minimum Variance Approach

Abstract: In this article, the recursive filtering problem is investigated for a class of discrete-time stochastic dynamical networks where the data delivery from the sensors to the filter is ...
Yahoo Finance

Assessing Recursion Pharmaceuticals (RXRX) Valuation As Shares Trade Below Fair Value Estimate

Recursion Pharmaceuticals (RXRX) shares recently closed at US$3.98, with the stock showing a negative return over the past month and past 3 months, which may prompt investors to reassess its current ...